Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.36 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.36 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.35 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | PTPN7 | P35236 | 5/20 | 0.33 |
| ▸ | HMGCR | P04035 | 3/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10163042 | 0.79 | EPHX2 (0.38) | LMNAEGLN1EPHX2PTPN7HMGCR | |
| SCHEMBL2396 | 0.77 | LMNA (0.42) | LMNAEGLN1ALKBH5SUCNR1MAPK1 | |
| SCHEMBL4972079 | 0.76 | LMNA (0.53) | LMNAEGLN1ALKBH5SUCNR1MAPK1 | |
| SCHEMBL9823904 | 0.75 | LMNA (0.40) | LMNAEGLN1ALKBH5SUCNR1MAPK1 | |
| SCHEMBL21847997 | 0.75 | FFAR3 (0.32) | FFAR3 | |
| SCHEMBL9677076 | 0.73 | ALDH1A1 (0.35) | LMNAPTPN7HMGCRHSD17B10TDP1 | |
| SCHEMBL416253 | 0.71 | HMGCR (0.52) | LMNAEGLN1ALKBH5SUCNR1EPHX2 | |
| SCHEMBL8847239 | 0.70 | EPHX2 (0.38) | LMNAEPHX2PTPN7HMGCRSLC22A6 | |
| SCHEMBL4241662 | 0.69 | HMGCR (0.50) | LMNAEGLN1ALKBH5SUCNR1EPHX2 | |
| SCHEMBL8847421 | 0.68 | FFAR1 (0.39) | LMNAEGLN1ALKBH5SUCNR1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4391139-A1 | ELECTROLYTE SOLUTION, ELECTROCHEMICAL DEVICE, SECONDARY BATTERY, AND LITHIUM ION SECONDARY BATTERY | DAIKIN INDUSTRIES, LTD. (JP) | 2024-06-26 | — | — | EP | disclosed |
| US-12015121-B2 | Electrolyte, electrochemical device, lithium ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2024-06-18 | — | — | US | disclosed |
| US-12002926-B2 | Electrolyte, electrochemical device, lithium ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2024-06-04 | — | — | US | disclosed |
| US-11996522-B2 | Electrolyte, electrochemical device, lithium-ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2024-05-28 | — | — | US | disclosed |
| US-20240154170-A1 | NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND ENERGY DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-05-09 | — | — | US | disclosed |
| US-20240145780-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY BATTERY, AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2024-05-02 | — | — | US | disclosed |
| US-11945776-B2 | Electrolyte, electrochemical device, lithium ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2024-04-02 | — | — | US | disclosed |
| US-11916195-B2 | Electrolyte solution, electrochemical device, lithium ion secondary battery, and module | DAIKIN INDUSTRIES, LTD. (JP) | 2024-02-27 | — | — | US | disclosed |
| EP-4293007-A1 | COMPOUND, COMPOSITION, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY AND MODULE | Daikin Industries, Ltd. (JP) | 2023-12-20 | — | — | EP | disclosed |
| US-20230387465-A1 | COMPOUND, COMPOSITION, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2023-11-30 | — | — | US | disclosed |
| US-20200274200-A1 | ELECTROLYTE FOR LITHIUM ION SECONDARY BATTERY, LITHIUM ION SECONDARY BATTERY, AND MODULE | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2020-08-27 | — | — | US | disclosed |
| US-20200274199-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-08-27 | — | — | US | disclosed |
| EP-3694041-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM-ION SECONDARY CELL, AND MODULE | Daikin Industries, Ltd. (JP) | 2020-08-12 | — | — | EP | disclosed |
| EP-3691016-A1 | ELECTROLYTE SOLUTION, ELECTROCHEMICAL DEVICE, AND LITHIUM ION SECONDARY BATTERY AND MODULE | Daikin Industries, Ltd. (JP) | 2020-08-05 | — | — | EP | disclosed |
| US-20200243911-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE | DAIKIN INDUSTRIES, LTD (JP) | 2020-07-30 | — | — | US | disclosed |
| EP-3686983-A1 | NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND ENERGY DEVICE | Mitsubishi Chemical Corporation (JP) | 2020-07-29 | — | — | EP | disclosed |
| US-20200220222-A1 | NONAQUEOUS ELECTROLYTE, NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND ENERGY DEVICE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-07-09 | — | — | US | disclosed |
| US-20200203769-A1 | ELECTROLYTE FOR LITHIUM ION SECONDARY BATTERY, LITHIUM ION SECONDARY BATTERY, AND MODULE | DAIKIN INDUSTRIES, LTD. (JP) | 2020-06-25 | — | — | US | disclosed |
| EP-3651255-A1 | ELECTROLYTE FOR LITHIUM ION SECONDARY BATTERY, LITHIUM ION SECONDARY BATTERY, AND MODULE | Daikin Industries, Ltd. (JP) | 2020-05-13 | — | — | EP | disclosed |
| EP-3641043-A1 | ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, LITHIUM ION SECONDARY BATTERY, AND MODULE | Daikin Industries, Ltd. (JP) | 2020-04-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203769-A1 | ELECTROLYTE FOR LITHIUM ION SECONDARY BATTERY, LITHIUM ION SECONDARY BATTERY, AND MODULE | CLIC1, CLIC4, CLCN2 | LMNA 2528/4885EGLN1 4343/4885ALKBH5 4411/4885 |
| US-20200274199-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND ENERGY DEVICE USING SAME | SLC26A3, VDAC3, SLC25A13 | LMNA 3230/4885EGLN1 2524/4885ALKBH5 4132/4885 |
| US-11945776-B2 | Electrolyte, electrochemical device, lithium ion secondary battery, and module | CLCN2, SLC26A3, KCNH3 | LMNA 2120/4885EGLN1 3770/4885ALKBH5 3623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.